Milademetan Uses, Dosage, Side Effects and more
Milademetan is under investigation in clinical trial NCT02319369 (Safety, Tolerability and Pharmacokinetics of Milademetan Alone and With 5-Azacitidine (AZA) in Acute Myelogenous Leukemia (AML) or High-Risk Myelodysplastic Syndrome (MDS)).
| Trade Name | Milademetan |
| Generic | Milademetan |
| Milademetan Other Names | Milademetan |
| Type | |
| Formula | C30H34Cl2FN5O4 |
| Weight | Average: 618.53 Monoisotopic: 617.1971882 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
